NEWS for Vaxart, Inc. … Munafa value: 40 as on 08 Fri Apr 2022. Downside target 4.5 Upside target 4.79...
Le plus ancien
vxrt stock
The biotech’s stock has been sliding hard over the past month and half for two related reasons: Vaxart’s oral COVID-19...
Out of 4 analysts, 3 (75%) are recommending VXRT as a Strong Buy, 0 (0%) are recommending VXRT as a...
What happened. Shares of Vaxart (Nasdaq: VXRT) rose on Monday after the biotech said the U.S. Food and Drug Administration...